TY - JOUR
T1 - Short-term results of changes in existing and de novo lower urinary tract symptoms after robot-assisted laparoscopic uterosacral ligament suspension and sacrocolpopexy
AU - Kurdoglu, Mertihan
AU - Unlu, Serdar
AU - Antonetti-Elford, Megan
AU - Kurdoglu, Zehra
AU - Kilic, Gokhan S.
N1 - Publisher Copyright:
© 2018 John Wiley & Sons Australia, Ltd
PY - 2019/4
Y1 - 2019/4
N2 - Objective: This study presents short-term outcomes related to changes in existing and de novo lower urinary tract symptoms (LUTS), pelvic pain, and bowel function following robot-assisted laparoscopic ute rosacral ligament suspension (RALUSLS) and sacrocolpopexy (RALSC). Methods: Observational data for RALUSLS (n = 23) and RALSC (n = 25) collected between August 2014 and March 2016 from a single institute (The University of Texas Medical Branch) were evaluated retrospectively. Patient characteristics, concomitant procedures, and the occurrence of lower urinary tract, pelvic pain, and bowel symptoms were compared between patients undergoing RALUSLS and RALSC. Results: There was no significant difference in background characteristics between the 2 groups, except for parity, which was high in the RALUSLS group. In the RALUSLS group, patients experienced significant resolution of urinary urgency (P <.001) and frequency, urge and mixed incontinence, and pelvic pain (P <.05). In the RALSC group, there was significant resolution of nocturia, mixed incontinence, pelvic pain, and dyspareunia (P <.05). There was no significant difference in the occurrence of de novo symptoms in the RALUSLS and RALSC groups (P >.05), although newly appearing urinary urgency or frequency and stress or urge incontinence were more common after RALSC. Conclusion: Mixed incontinence and pelvic pain improved significantly in patients after RALUSLS or RALSC. In RALUSLS patients, urgency, frequency, and urge incontinence also improved, whereas additional improvement in nocturia and dyspareunia was evident only in RALSC patients. De novo LUTS developing after these procedures, especially after RALSC, necessitate careful patient consultation prior to surgery.
AB - Objective: This study presents short-term outcomes related to changes in existing and de novo lower urinary tract symptoms (LUTS), pelvic pain, and bowel function following robot-assisted laparoscopic ute rosacral ligament suspension (RALUSLS) and sacrocolpopexy (RALSC). Methods: Observational data for RALUSLS (n = 23) and RALSC (n = 25) collected between August 2014 and March 2016 from a single institute (The University of Texas Medical Branch) were evaluated retrospectively. Patient characteristics, concomitant procedures, and the occurrence of lower urinary tract, pelvic pain, and bowel symptoms were compared between patients undergoing RALUSLS and RALSC. Results: There was no significant difference in background characteristics between the 2 groups, except for parity, which was high in the RALUSLS group. In the RALUSLS group, patients experienced significant resolution of urinary urgency (P <.001) and frequency, urge and mixed incontinence, and pelvic pain (P <.05). In the RALSC group, there was significant resolution of nocturia, mixed incontinence, pelvic pain, and dyspareunia (P <.05). There was no significant difference in the occurrence of de novo symptoms in the RALUSLS and RALSC groups (P >.05), although newly appearing urinary urgency or frequency and stress or urge incontinence were more common after RALSC. Conclusion: Mixed incontinence and pelvic pain improved significantly in patients after RALUSLS or RALSC. In RALUSLS patients, urgency, frequency, and urge incontinence also improved, whereas additional improvement in nocturia and dyspareunia was evident only in RALSC patients. De novo LUTS developing after these procedures, especially after RALSC, necessitate careful patient consultation prior to surgery.
KW - digestive signs and symptoms
KW - lower urinary tract symptoms
KW - pelvic pain
KW - prolapse
KW - robotics
KW - surgical procedures
UR - http://www.scopus.com/inward/record.url?scp=85064816706&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064816706&partnerID=8YFLogxK
U2 - 10.1111/luts.12219
DO - 10.1111/luts.12219
M3 - Article
C2 - 29508556
AN - SCOPUS:85064816706
SN - 1757-5664
VL - 11
SP - O71-O77
JO - LUTS: Lower Urinary Tract Symptoms
JF - LUTS: Lower Urinary Tract Symptoms
IS - 2
ER -